
Securities Fraud Allegations: Essa Pharma Faces Lawsuit for Potential Investor Deception
Important Information for Investors: Class Action Lawsuit Against ESSA Pharma Inc. In a significant development, The Schall Law Firm has announced that it is representing investors who purchased securities of ESSA Pharma Inc. (“ESSA” or “the Company”) (NASDAQ:EPIX) during the period from December 12, 2023, to October 31, 2024, inclusive (the “Class Period”). The firm…